VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,091,000 | -19.5% | 46,929 | -44.9% | 0.47% | -6.7% |
Q1 2018 | $1,356,000 | +513.6% | 85,200 | +326.0% | 0.51% | +614.1% |
Q1 2017 | $221,000 | -59.8% | 20,000 | -10.7% | 0.07% | -65.2% |
Q3 2016 | $550,000 | -31.9% | 22,400 | -44.1% | 0.20% | -24.4% |
Q2 2016 | $808,000 | +127.6% | 40,100 | +197.0% | 0.27% | +134.8% |
Q1 2016 | $355,000 | -55.2% | 13,500 | +73.1% | 0.12% | -56.6% |
Q4 2015 | $793,000 | -61.3% | 7,800 | -32.2% | 0.26% | -61.3% |
Q3 2015 | $2,051,000 | -54.1% | 11,500 | -42.8% | 0.68% | -48.0% |
Q2 2015 | $4,465,000 | +2.2% | 20,100 | -8.6% | 1.32% | -8.7% |
Q1 2015 | $4,370,000 | +59.0% | 22,000 | +14.6% | 1.44% | +34.0% |
Q4 2014 | $2,748,000 | – | 19,200 | – | 1.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |